Health Canada drug identification number

DIN 02231330 — APO-FLUVOXAMINE 100 MG

APO-FLUVOXAMINE is a tablet of Fluvoxamine marketed by APOTEX INC. The full Fluvoxamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02231330
Brand name
APO-FLUVOXAMINE
Active ingredient
Fluvoxamine
Strength
100 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
APOTEX INC
Health Canada status
MARKETED
Drug class
Selective serotonin reuptake inhibitor (SSRI) antidepressant

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Fluvoxamine products

DINBrandStrengthFormManufacturerStatus
02231329 APO-FLUVOXAMINE 50 MG TABLET APOTEX INC MARKETED
01919369 LUVOX 100 MG TABLET BGP PHARMA ULC MARKETED
01919342 LUVOX 50 MG TABLET BGP PHARMA ULC MARKETED
02255537 TEVA-FLUVOXAMINE 100 MG TABLET TEVA CANADA LIMITED MARKETED
02255529 TEVA-FLUVOXAMINE 50 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.